[1]
2022. Changes of peri-implant bone density in relation to local application of alendronate and/or recombinant human bone morphogenetic protein-2: A randomized controlled clinical study. Journal of Osseointegration. 14, 3 (Sep. 2022), 185–193. DOI:https://doi.org/10.23805/JO.2022.14.30.